Contact us about investment opportunities or you can invest:

    Financial Planning

    By talking to your financial advisor about how investing in ROBO Global ETFs can help meet your financial objectives

    online trading

    Through your online brokerage account with access to the New York Stock Exchange listings

    Why You Should Consider Allocating to A Disruptive Technology ETF

    One trade away from exposure to the world of disruptive technology. Investors are able to access a basket of innovative stocks through our three ETFs. Our portfolios provide broad global exposure to cutting-edge companies in robotics, AI, and healthcare technology.

    • Broad Exposure to Rapidly Evolving Technologies

      Investing in the ROBO Global ETFs provides access to companies that we consider to be disruptive across multiple geographies, sectors, and market caps.

    • Access to Thorough Research & Quarterly Rebalances

      Our team of financial professionals and industry experts are wholly focused on constructing disruptive technology portfolios. We conduct in-depth research across robotics, AI, and healthcare technology, with the goal of reflecting the most timely developments and innovative companies in the space.

    • A Liquid, Tax Efficient Investment Vehicle

      An ETF wrapper presents a tax-efficient vehicle for exposure to broad range technology companies. In a single trade, investors are allocating to companies across the world working in disruptive technology. The nature of this disruption can potentially create an environment ripe for M&A activity.

    • Long-term, Future-Focused Investment Strategies

      Our portfolios are built for the long-term. Because these technologies are changing so quickly, we believe that ETF investing is the best way to potentially capture these often unstructured, long-term growth opportunities.

    • Low Overlap with Traditional Broad Market Indices 

      Investors are receiving additional exposure to companies that are not found in traditional market indices.

       

    News Feed

    Turnkey Tech Investing: Feb 2023 Market Brief
    Turnkey Tech Investing: Feb 2023 Market Brief

    By Bill Studebaker, CIO & President, ROBO Global 

    Read More
    How Liquid Biopsy Is Bringing Earlier Cancer Detection to the Horizon
    How Liquid Biopsy Is Bringing Earlier Cancer Detection to the Horizon

    While much of the healthcare industry’s attention over the past two years has been fixated on...

    Read More
    Turnkey Tech Investing: Jan 2023 Market Brief
    Turnkey Tech Investing: Jan 2023 Market Brief

    By Bill Studebaker, CIO & President, ROBO Global 

    Read More

    logo-white

    Providing investors with a liquid, cost-effective and diversified way
    to gain access to rapidly evolving robotics technology and AI

    Navigation

        contacts

        © 2013 - 2022 ROBO Global ETFs. All rights reserved.

        Exchange Traded Concepts, LLC serves as the investment advisor of the funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Exchange Traded Concepts, LLC or any of its affiliates. Check the background of SIDCO on FINRA’s BrokerCheck.

        Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found on the Funds' full or summary prospectuses, which may be obtained at www.roboglobaletfs.com. Read the prospectus carefully before investing.

        Investing involves risk, including the possible loss of principal. International investments may also involve risk from unfavorable fluctuations in currency values, differences in generally accepted accounting principles, and from economic or political instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and lower trading volume. Narrowly focused investments and investments in smaller companies typically exhibit higher volatility. There is no guarantee the funds will achieve their stated objective. ROBO, HTEC, and THNQ are non-diversified.

        The liquidity of the A-shares market and trading prices of A-shares could be more severely affected than the liquidity and trading prices of other markets because the Chinese government restricts the flow of capital into and out of the A-shares market. The funds may experience losses due to illiquidity of the Chinese securities markets or delay or disruption in execution or settlement of trades.

        The risks associated with investments in Robotics and Automation Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Robotics and Automation Companies, especially smaller, start-up companies, tend to be more volatile than securities of companies that do not rely heavily on technology. Rapid change to technologies that affect a company's products could have a material adverse effect on such company's operating results. Robotics and Automation Companies may rely on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies' technology.

        The risks associated with Artificial Intelligence (AI) Companies include, but are not limited to, small or limited markets, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation. Rapid change to technologies that affect a company’s products could have a material adverse effect on such company’s operating results. AI Companies also rely heavily on a combination of patents, copyrights, trademarks and trade secret laws to establish and protect their proprietary rights in their products and technologies. There can be no assurance that the steps taken by these companies to protect their proprietary rights will be adequate to prevent the misappropriation of their technology or that competitors will not independently develop technologies that are substantially equivalent or superior to such companies’ technology. AI Companies typically engage in significant amounts of spending on research and development, and there is no guarantee that the products or services produced by these companies will be successful.

        The risks associated with Medical Technology Companies include, but are not limited to, small or limited markets for such securities, changes in business cycles, world economic growth, technological progress, rapid obsolescence, and government regulation.

        Diversification may not protect against market risk.

        Privacy Policy

        Beginning September 2, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to September 2, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times.